Dr. Aditya Bagrodia

Radical therapy remains the cornerstone in the treatment of high-risk prostate cancer, encompassing modalities such as radical prostatectomy and brachytherapy. Criteria for the high-risk prostate cancer designation typically include a Gleason score ranging from 8 to 10, grade 4 or 5, or PSA levels surpassing 20.

Urologic oncologist Dr. Aditya Bagrodia and radiation oncologist Dr. Daniel Spratt explain their approach to radiation therapy in high-risk prostate cancer treatment, emphasizing the latest clinical evidence.

This practical guide walks urologists through how to perform the transperineal prostate biopsy procedure. Key concepts for beginning physicians include unlearning transrectal biopsy habits and becoming proficient in the freehand technique to enhance precision.

Which is better, transrectal or transperineal prostate biopsy? Three leading urologists discuss prostate biopsy procedures, considering safety, cancer detection rates, and more!

Urologists Aditya Bagrodia, Matt Allaway, and Juan Javier-DesLoges explore the role of various equipment, tools, and instruments in switching from a traditional transrectal biopsy to the more efficient transperineal biopsy approach.

TULSA prostate treatment is a new prostate cancer treatment option that uses real-time MRI thermometry to visualize treatment areas and boundaries. TULSA treatment for prostate cancer requires proper patient selection and preparation are crucial for success. Learn more!

The TULSA procedure for the treatment of prostate cancer involves several technical steps, including imaging, device placement, ablation control, & real-time monitoring. Learn more in this guide.

Transurethral ultrasound ablation may offer distinct advantages over alternative treatment options for prostate cancer. Xioasong Meng and Dr. Aditya Bagrodia team up with radiologist Dr. Daniel Costa to explain how to establish a TULSA program for prostate cancer treatment.

The management of high-grade BCG-unresponsive bladder cancer begins with the establishment of cytology and, based on the patient profile, is followed by either TURBT or total cystectomy. Alternatives to BCG for bladder cancer are available, but ongoing research continues to explore other options.

BCG-unresponsive bladder cancer has distinct criteria for diagnosis and management. Official FDA diagnosis requires the development or recurrence of a high-grade bladder tumor after a patient has received adequate BCG therapy. Treatment duration varies based on whether an induction or maintenance course is indicated.

The TURBT procedure for bladder cancer is a common procedure. Urologist Dr. Chang shares his approach to successful bladder cancer resection with TURBT, covering his technique before, during, & after.

Upper tract urothelial carcinoma is a rare entity with a lack of prospective data to guide clinical decisions. Dr. Shariat, who led the charge on building multicenter data sets for the condition, joins Dr. Bagrodia to discuss surgical management.

Urologists commonly utilize radiotherapy in the treatment of prostate cancer, but like most treatment modalities, it is not without its complications. Learn more about specific complications and the role of patient-specific and prostate-specific factors in determining candidacy for treatment. 

Internal radiation therapy and external radiation therapy are often used by Urologists in the treatment of prostate cancer. Understanding the differences between the two forms of radiation is pertinent for deciding the patient's treatment plan.

Many transgender individuals undergo gender affirming pelvic surgery, or bottom surgery. This article discusses common bottom surgery complications and their management.

Transgender and gender diverse patients often seek urological care when they are interested in gender affirming surgery. This article discusses terminology and gender affirming surgery options available to transgender patients.

Blue light cystoscopy is useful in managing bladder cancer, both for complete tumor resection in the OR and as routine surveillance office cystoscopy to monitor bladder cancer recurrence.

When deciding on prostate cancer surgery vs radiation, it is important to know all of the pros and cons. They can both be effective treatments for prostate cancer, but you should be informed of the risks based on your age. This article covers both prostate cancer treatments.

This article discusses the criteria to start prostate cancer active surveillance, various modalities to monitor disease progression, and indications to initiate other treatment.

A ureteroscopy should be performed if a stone fails trial of passage. This article breaks down the peri-operative and post-op care, as well as technique for this procedure.

Obstructive pyelonephritis can present as an emergency, and must be correctly identified and treated. This article discusses the diagnosis and treatment of this condition, along with medical management of a trial of passage.

Kidney cancer surgery can be aggressive or conservative, depending on various factors. This article discusses when to perform a partial vs. radical nephrectomy, the indications for lymph node dissection, and the viability of a robotic approach.

Tumor thrombus formation is common in locally advanced kidney cancer, and can lead to bland thrombus, pulmonary emboli, and even Budd-Chiari syndrome. The risk of pulmonary emboli creates unique challenges during kidney cancer surgery.

PCNL is a minimally invasive surgical procedure that is used to remove large or complex kidney stones. Urologist Dr. Margaret Pearle explains when nephrostomy tube placement is appropriate and how they can stabilize post-operative bleeding.